<code id='10B77FA999'></code><style id='10B77FA999'></style>
    • <acronym id='10B77FA999'></acronym>
      <center id='10B77FA999'><center id='10B77FA999'><tfoot id='10B77FA999'></tfoot></center><abbr id='10B77FA999'><dir id='10B77FA999'><tfoot id='10B77FA999'></tfoot><noframes id='10B77FA999'>

    • <optgroup id='10B77FA999'><strike id='10B77FA999'><sup id='10B77FA999'></sup></strike><code id='10B77FA999'></code></optgroup>
        1. <b id='10B77FA999'><label id='10B77FA999'><select id='10B77FA999'><dt id='10B77FA999'><span id='10B77FA999'></span></dt></select></label></b><u id='10B77FA999'></u>
          <i id='10B77FA999'><strike id='10B77FA999'><tt id='10B77FA999'><pre id='10B77FA999'></pre></tt></strike></i>

          focus

          focus

          author:entertainment    Page View:6845
          John-Arne-Røttingen, a white man with short hair, smiles at the camera wearing blue suits — biotech coverage from STAT
          John-Arne Røttingen is the head of the Wellcome Trust, one of the world’s top private funders of biomedical research. Illustration: STAT; Source: Wellcome Trust

          LONDON — The key groups involved in addressing global health problems often include governments, foundations, and pharmaceutical companies.

          But to John-Arne Røttingen, the new head of the Wellcome Trust, one of the world’s top private funders of biomedical research, there’s another sector that should be getting involved — the tech industry.

          advertisement

          The Alphabets and Amazons of the world have been growing their health-related initiatives, but the industry is rarely mentioned when neglected public health issues are discussed, Røttingen argued.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more
          Ending racial health disparities hinges on penalties, political will
          Ending racial health disparities hinges on penalties, political will

          AdobeThenation’swidespreadracialhealthdisparitieswon’tbeerasedwithoutchangestohowhealthcaresystemsar

          read more
          Malaria cases in Florida and Texas: Here’s what you need to know
          Malaria cases in Florida and Texas: Here’s what you need to know

          MosquitoscaughtfortestingawaitshipmenttoalabinMcAllen,Texas,inApril2016tobetestedformosquito-bornedi

          read more

          Indian pharmaceutical industry in denial over drug

          AchemistworksatapharmaceuticalmanufacturingplantontheoutskirtsofMumbai.Drugmakersinthecountryhavecom